METRO UMKAL HOSPITAL & HEART INSTITUTE

Details

Name :

METRO UMKAL HOSPITAL & HEART INSTITUTE

Address  :

Circular Road,
Dharuhera Chungi,
Rewari

Town  :

Hisar

State  :

Haryana

Country  :

INDIA

Post Code:

123401

Phone  :

+91 127 4252033

Fax  :

01274-252433

Web URL  :

METRO UMKAL HOSPITAL  HEART INSTITUTE
Specialization
  • Cardiology
  • Cardiothoracic Surgeon
  • Dentistry
  • Internal Medicine
Facilities

Total Number Of Beds : 51

Speciality Type :

  • Single Speciality : Cardiology

Other Facilities

  • Pathology
  • Ultrasonography
  • Physiotherapy

Advance Facility

  • Medical Stores

Description

Metro Umkal Hospital amp Heart Institute Rewari is state of the art 51 bedded Cardiac superspecialty hospital located at Dharuhera Chungi Circular Road Rewari Haryana The Hospital has already made tremendous difference in the quality of cardiac care in Rewari The hospital provides preventive diagnostic and therapeutic cardiac care services under one roof

Metro Umkal Hospital amp Heart Institute offers facilities in invasive cardiology like Angiography Angioplasty Stenting Bypass surgery Open Heart Surgery Valve Replacement Pace maker implantations etc as well as in non Invasive cardiology like Echo TMT ECG Holter etc The patients of this region have been benefited by quality clinical and interventional procedure

The Hospital provides a comfortable environment for patients and their attendants though different category of Rooms likes Single Room Double Room General wards All the rooms and general wards are fully airconditioned and we also have cafeteria to provide good food to the patients and their attendants
Stemis hitech aid reaches out to heart attack patients

If you have a heart attack and call the governmentrun EMRI ambulance chances are that you will land up in the care of the most experienced cardiologists in the country A group of doctors here has put together a unique technologypowered System of Care to make sure every heart attack victim in the state gets treated in time Using 3G technology smar... Read More

Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More